Literature DB >> 12630996

Localization of breast sentinel lymph nodes by MR lymphography with a conventional gadolinium contrast agent. Preliminary observations in dogs and humans.

K Suga1, Y Yuan, N Ogasawara, M Okada, N Matsunaga.   

Abstract

PURPOSE: To test the capability of an indirect MR lymphography (MRLG) using a conventional extracellular gadolinium (Gd)-based contrast agent for localizing breast sentinel lymph node (SLN).
METHODS: A total of 1 and 0.5 ml of undiluted gadopentetate dimeglumine were injected subcutaneously into the two periareolar areas overlying each caudal mammary gland in 10 female dogs. Contiguous 2-mm-thick fast gradient echo MR images were acquired through the upper breast and axilla before and for 60 min after gentle massage at the injection sites, yielding 3D displays. The localized SLN was resected from the living animals, followed by post mortem examinations. MRLG (1 ml contrast agent injected) was also attempted in 5 female volunteers.
RESULTS: Even with 0.5-ml contrast agent, the MRLG clearly visualized the connection of SLN and lymphatic vessels directly draining from the injection sites, and the remaining distant nodes, with the maximal enhancement peaks within 10 min after massage. The 3D images provided comprehensive anatomy of these lymphatic pathways in each axilla. Of the 20 SLN and 128 distant nodes visualized on the MRLG, all the SLN (100%) and 107 (83.5%) distant nodes could be resected pre- and post mortem, in good correlation with the locations and sizes on the MR images. MRLG also effectively localized SLN in the volunteers, without significant adverse effects.
CONCLUSION: An indirect MRLG using small volumes of conventional Gd-based contrast agent may have potential for accurate identification and surgical biopsy of breast SLN.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12630996

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  12 in total

1.  Indirect magnetic resonance lymphography of the head and neck of dogs using Gadofluorine M and a conventional gadolinium contrast agent: a pilot study.

Authors:  Monique N Mayer; Susan L Kraft; Daniel S Bucy; Cheryl L Waldner; Kirsten M Elliot; Sheldon Wiebe
Journal:  Can Vet J       Date:  2012-10       Impact factor: 1.008

2.  Percutaneous removal of sentinel lymph nodes in a swine model using a breast lesion excision system and contrast-enhanced ultrasound.

Authors:  Ali R Sever; Philippa Mills; Jean-Marc Hyvelin; Jennifer Weeks; Hatice Gumus; David Fish; Willem Mali; Susan E Jones; Peter A Jones; Haresh Devalia
Journal:  Eur Radiol       Date:  2011-10-07       Impact factor: 5.315

3.  Detection of lymph node involvement in hematologic malignancies using micromagnetic resonance lymphangiography with a gadolinum-labeled dendrimer nanoparticle.

Authors:  Hisataka Kobayashi; Satomi Kawamoto; Martin W Brechbiel; Marcelino Bernardo; Noriko Sato; Thomas A Waldmann; Yutaka Tagaya; Peter L Choyke
Journal:  Neoplasia       Date:  2005-11       Impact factor: 5.715

4.  Synergistic enhancement of iron oxide nanoparticle and gadolinium for dual-contrast MRI.

Authors:  Fan Zhang; Xinglu Huang; Chunqi Qian; Lei Zhu; Naoki Hida; Gang Niu; Xiaoyuan Chen
Journal:  Biochem Biophys Res Commun       Date:  2012-08-07       Impact factor: 3.575

Review 5.  Contrast-enhanced MR imaging of lymph nodes in cancer patients.

Authors:  Seung Hong Choi; Woo Kyung Moon
Journal:  Korean J Radiol       Date:  2010-06-21       Impact factor: 3.500

6.  Dynamic contrast-enhanced magnetic resonance imaging of tumor-induced lymph flow.

Authors:  Alanna Ruddell; Maria I Harrell; Satoshi Minoshima; Kenneth R Maravilla; Brian M Iritani; Steven W White; Savannah C Partridge
Journal:  Neoplasia       Date:  2008-07       Impact factor: 5.715

Review 7.  MR imaging of the breast: indications, established technique, and new directions.

Authors:  F Sardanelli; A Iozzelli; A Fausto
Journal:  Eur Radiol       Date:  2003-11       Impact factor: 7.034

8.  Sentinel lymph node detection using magnetic resonance lymphography with conventional gadolinium contrast agent in breast cancer: a preliminary clinical study.

Authors:  Chuanming Li; Shan Meng; Xinhua Yang; Daiquan Zhou; Jian Wang; Jiani Hu
Journal:  BMC Cancer       Date:  2015-04-02       Impact factor: 4.430

9.  Imaging lymphatic system in breast cancer patients with magnetic resonance lymphangiography.

Authors:  Qing Lu; Jia Hua; Mohammad M Kassir; Zachary Delproposto; Yongming Dai; Jingyi Sun; Mark Haacke; Jiani Hu
Journal:  PLoS One       Date:  2013-07-05       Impact factor: 3.240

Review 10.  Theranostics and contrast agents for magnetic resonance imaging.

Authors:  Yohan Jeong; Hee Sook Hwang; Kun Na
Journal:  Biomater Res       Date:  2018-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.